EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HIF-1α Signaling in Uterine Fibroids: A Central Integrator of Hypoxic, Hormonal, and Fibrotic Pathways

Sruthi Tatavarthi, Valentina Vanos, Abigail Lepsch Combs, Alvina Pan, Mahita Saini, Mostafa A Borahay

Oxygen · 17.04.2026 · 6 (2) · 9

DOI: 10.3390/oxygen6020009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oxygen, online erschienen am 17.04.2026. Verfasst von Sruthi Tatavarthi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Johns Hopkins University Krieger School of Arts and Sciences, Baltimore, MD 21218, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Uterine fibroids (leiomyomas) are common benign smooth muscle tumors that impose substantial symptom burden and healthcare costs worldwide. Although uterine fibroid (leiomyoma) pathogenesis is multifactorial, hypoxia has emerged as a key feature of the uterine fibroid (leiomyoma) microenvironment, particularly within poorly perfused tumor cores. Hypoxia-inducible factor-1α (HIF-1α) is a central transcriptional regulator of cellular adaptation to low oxygen and coordinates downstream programs that support angiogenesis, metabolic reprogramming, cell survival, and extracellular matrix (ECM) remodeling. In uterine fibroids (leiomyomas), these HIF-1α–dependent processes intersect with steroid hormone signaling, growth factor pathways, inflammatory mediators, and redox imbalance, together promoting tumor persistence and progressive fibrosis. This review synthesizes the molecular regulation of HIF-1α, highlights major HIF-linked effector pathways relevant to uterine fibroid (leiomyoma) biology, and emphasizes mechanistic crosstalk with estrogen- and progesterone-responsive signaling, TGF-β/SMAD-driven fibrosis, NF-κB-mediated inflammation, and metabolic checkpoint pathways including mTOR and AMPK. Finally, we evaluate emerging therapeutic strategies that target HIF-1α directly or indirectly through upstream regulators.

Schlagwörter

Stichwörter der Autor:innen

GLUT1HIF-1αTGF-β/SMAD pathwayVEGFmTORreactive oxygen speciesuterine fibroids

Autor:innen und Institutionen

  • Johns Hopkins University Krieger School of Arts and Sciences, Baltimore, MD 21218, USA.
  • Department of Population, Family, and Reproductive Health, Bloomberg School of Public Health, Baltimore, MD 21205 USA.
  • Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
  • Johns Hopkins University Advanced Academic Programs, Baltimore, MD 21218, USA.

Förderung

  • NICHD NIH HHS
  • National Institutes of Health

Zitieren

APA

Tatavarthi, S., Vanos, V., Combs, A. L., Pan, A., Saini, M., & Borahay, M. A. (2026). HIF-1α Signaling in Uterine Fibroids: A Central Integrator of Hypoxic, Hormonal, and Fibrotic Pathways. Oxygen, 6(2), 9. https://doi.org/10.3390/oxygen6020009

Vancouver

Tatavarthi S, Vanos V, Combs AL, Pan A, Saini M, Borahay MA. HIF-1α Signaling in Uterine Fibroids: A Central Integrator of Hypoxic, Hormonal, and Fibrotic Pathways. Oxygen. 2026;6(2):9. doi:10.3390/oxygen6020009

BibTeX
@article{Tatavarthi2026,
  author = {Tatavarthi, Sruthi and Vanos, Valentina and Combs, Abigail Lepsch and Pan, Alvina and Saini, Mahita and Borahay, Mostafa A},
  title = {HIF-1α Signaling in Uterine Fibroids: A Central Integrator of Hypoxic, Hormonal, and Fibrotic Pathways},
  journal = {Oxygen},
  year = {2026},
  volume = {6},
  number = {2},
  pages = {9},
  doi = {10.3390/oxygen6020009}
}
Kostenlos starten →